- Home
- PULM vs OKUR Comparison
PULM vs OKUR Comparison
Compare PULM & OKUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PULM
- OKUR
- Stock Information
- Founded
- PULM 2003
- OKUR 2011
- Country
- PULM United States
- OKUR United States
- Employees
- PULM N/A
- OKUR N/A
- Industry
- PULM Biotechnology: Pharmaceutical Preparations
- OKUR
- Sector
- PULM Health Care
- OKUR
- Exchange
- PULM Nasdaq
- OKUR NYSE
- Market Cap
- PULM 33.2M
- OKUR 34.9M
- IPO Year
- PULM N/A
- OKUR N/A
- Fundamental
- Price
- PULM $5.62
- OKUR $2.31
- Analyst Decision
- PULM
- OKUR Strong Buy
- Analyst Count
- PULM 0
- OKUR 4
- Target Price
- PULM N/A
- OKUR $32.25
- AVG Volume (30 Days)
- PULM 11.2K
- OKUR 73.5K
- Earning Date
- PULM 08-12-2025
- OKUR 08-14-2025
- Dividend Yield
- PULM N/A
- OKUR N/A
- EPS Growth
- PULM N/A
- OKUR N/A
- EPS
- PULM N/A
- OKUR N/A
- Revenue
- PULM $1,921,000.00
- OKUR N/A
- Revenue This Year
- PULM N/A
- OKUR N/A
- Revenue Next Year
- PULM $134.88
- OKUR N/A
- P/E Ratio
- PULM N/A
- OKUR N/A
- Revenue Growth
- PULM N/A
- OKUR N/A
- 52 Week Low
- PULM $1.78
- OKUR $1.70
- 52 Week High
- PULM $10.40
- OKUR $20.00
- Technical
- Relative Strength Index (RSI)
- PULM 32.49
- OKUR N/A
- Support Level
- PULM $5.60
- OKUR N/A
- Resistance Level
- PULM $6.15
- OKUR N/A
- Average True Range (ATR)
- PULM 0.28
- OKUR 0.00
- MACD
- PULM -0.05
- OKUR 0.00
- Stochastic Oscillator
- PULM 1.63
- OKUR 0.00
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
About OKUR ONKURE THERAPEUTICS INC
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. The company operates in one operating segment which is clinical research. It has a pipeline of tumor-agnostic candidates that are designed to achieve optimal efficacy and tolerability.